Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Bio-Techne Corporation

< Previous 1 2 3 4 5 6 7 Next >
Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results
Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, February 2, 2021, at 8:00 a.m. CST to review second quarter 2021 financial... 
Tickers TECH
From PR Newswire
Bio-Techne To Present At The 39th Annual J.P. Morgan Healthcare Conference
Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January... 
Tickers TECH
From PR Newswire
Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development
Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal... 
Tickers RGLS TECH
From PR Newswire
Bio-Techne To Present At The Stephens Annual Investment Conference 2020
Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Stephens Annual Investment Conference 2020 on Tuesday, November 17,... 
Tickers TECH
From PR Newswire
Bio-Techne Declares Dividend
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2020. The quarterly dividend will be... 
Tickers TECH
From PR Newswire
Bio-Techne Releases First Quarter Fiscal 2021 Results
Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2020. 
Tickers TECH
From PR Newswire
Bio-Techne To Present At The Stifel 2020 Virtual Healthcare Conference
Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Stifel 2020 Virtual Healthcare Conference on Monday, November 16,... 
Tickers TECH
From PR Newswire
Bio-Techne To Present At The 29th Annual Credit Suisse Virtual Healthcare Conference
Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Wednesday, November 11,... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Commercial Release Of New SARS-CoV-2 Multi-Antigen Serology Assay Kit For Simple Western
New serology assay accelerates COVID-19 research and vaccine development through rapid characterization of human immune response to multiple SARS-CoV-2 antigens 
Tickers TECH
From PR Newswire
Bio-Techne Announces ISO 13485:2016 Certification for the Woburn, MA Manufacturing Facility
Bio-Techne Corporation (NASDAQ: TECH), a leading provider of proteins, antibodies and cytokines today announced that its Woburn, Massachusetts site received ISO 13485:2016 certification for Medical... 
Tickers TECH
From PR Newswire
Bio-Techne To Host Conference Call On November 5, 2020 To Announce First Quarter 2021 Financial Results
Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, November 5, 2020, at 8:00 a.m. CST to review first quarter 2021 financial... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Opening Of New Canadian Facility
Bio-Techne Corporation (NASDAQ:TECH) today announced the opening of its new Canadian office located in Toronto. This new office will be the workplace for approximately 40 Bio-Techne employees and... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Grand Opening Of GMP Manufacturing Facility
Bio-Techne Corporation (NASDAQ: TECH) today announced the grand opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing Practices) manufacturing facility. Located in... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Publication Of ExoDx Prostate Test Study In Patients With Prior Negative Prostate Biopsy
Bio-Techne Corporation (NASDAQ:TECH) today announced an important publication in BMC Urology, entitled A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Commercial Release Of New Co-Detection Assays For Simultaneous Detection Of RNA And Protein On The Same Sample
Expanding Bio-Techne's lead in providing multi-omics research tools to co-detect RNA and protein targets 
Tickers TECH
From PR Newswire
Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The R&D Systems Product Portfolio
Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic manufacturing services, and its proprietary... 
Tickers TECH
From PR Newswire
Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership
Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma... 
Tickers TECH
From PR Newswire
Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise Awareness And Education To Empower Men With Prostate Cancer
Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with Hall of Famer and baseball's all-time "Iron Man", Cal Ripken... 
Tickers TECH
From PR Newswire
Bio-Techne To Present At The 2020 Wells Fargo Virtual Healthcare Conference
Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2020 Wells Fargo Virtual Healthcare Conference on Wednesday,... 
Tickers TECH
From PR Newswire
Bio-Techne Corporation and Leica Biosystems are Accelerating Disease Research with RNAscope™ COVID-19 Probes and the BOND RX*
Research-use-only RNA-ISH probes now available for COVID-19 on our automated platform 
Tickers TECH
From PR Newswire
Bio-Techne Announces Release of a New SARS-CoV-1/2 Spike RBD LlaMABody™ Recombinant Antibody that Blocks Viral Entry
Bio-Techne Corporation (NASDAQ:TECH) today announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds to the SARS-CoV-2 spike receptor binding domain (RBD) and... 
Tickers TECH
From PR Newswire
Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler
Curated Menu of Off-the-Shelf RNAscope Probes Provide Molecularly-Guided Region of Interest Selection for Use with the New NGS-Enabled Cancer Transcriptome Atlas 
Tickers NSTG TECH
From PR Newswire
Bio-Techne Releases Fourth Quarter Fiscal 2020 Results
Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2020. 
Tickers TECH
From PR Newswire
Bio-Techne Declares Dividend
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2020. The quarterly dividend will be payable... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Appointment Of Julie L. Bushman To Its Board Of Directors
Bio-Techne Corporation (NASDAQ:TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board of directors, effective as of July 31, 2020.... 
Tickers TECH
From PR Newswire
Bio-Techne And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test
Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Launch Of ExoCovid-19 Test For Detection Of SARS-CoV-2 In Patient Samples
Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now... 
Tickers TECH
From PR Newswire
Bio-Techne Announces Commercial Release Of New Assay For Detecting ASOs, miRNAs, And siRNAs In Tissue
Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. 
Tickers TECH
From PR Newswire
Bio-Techne To Host Conference Call On August 4, 2020 To Announce Fourth Quarter 2020 Financial Results
Tickers TECH
From PR Newswire
Bio-Techne And ZERO - The End Of Prostate Cancer Announce Partnership To Fund Education And Awareness Campaigns To Empower Men With Prostate Cancer
Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national... 
Tickers TECH
From PR Newswire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.